Sign in
CompletedNo phase

High-frequency Alternating Current Stimulation for Neurophatic Pain in Spinal Cord Injury

Key facts

Who runs it
University of Castilla-La Mancha
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
30 Jan 2026
Ended
7 Apr 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Active group 40 kHz
  • Sham intervention
Record updated
13 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • People with spinal cord injuries of any aetiology affecting the D1 spinal cord level or lower (paraplegia)
  • With injury grade A, B, C, or D according to the ASIA (American Spinal Injury Association) Impairment Scale (AIS)
  • Time since spinal cord injury ≥ 3 months
  • A score of ≥ 4 points on the Dolour Neuropathique 4 (DN4) scale
  • Neuropathic pain at the level of the injury (within the dermatome at that level and up to three dermatomes below) and/or below the level of the injury (more than three dermatomes below)
  • Duration of pain ≥ 1 month
  • Average pain perception score ≥ 30 mm on the visual analogue scale (VAS) in the week prior to eligibility, with a daily record of 5 days (Monday to Friday) in the morning
  • Be able to understand instructions and assessment tools
  • Agree to participate in the study and sign the informed consent form

Who cannot take part

  • Brain injuries or other central nervous system injuries concomitant with spinal cord injury
  • A value of 100 mm in any of the daily records collected in the week prior to eligibility
  • Changes in medication prescribed for the treatment of pain and spasticity during the study
  • Having any contraindications for the application of transcutaneous electrical stimulation: cardiac pacemaker or any other implanted electrical device, epilepsy, pregnancy, active malignant tumours in the area of application of the stimulation, and wounds or skin damage in the area of stimulation
  • History of psychiatric illness
  • Cauda equina injuries
  • Major depression
  • Spinal cord injury caused by autolysis
  • Acute nociceptive pain in any area of the body during the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To investigate the safety and effectiveness of transcutaneous electrical stimulation with 40 kHz alternating currents combined with standard treatment compared to placebo electrical stimulation plus standard treatment for neuropathic pain in people with spinal cord injury.

The 2 groups in the trial

  • Experimental: 40 kHzTreatment being tested

    Alternating current stimulation with a 40kHz frequency with a transcutaneous approach, 20 minutes for each intervention.

    Treatment: Active group 40 kHz

  • Sham stimulationSham treatment, for comparison

    Sham stimulation via transcutaneous approach will be delivered only for the first 30 seconds, following the same procedures as the 40kHz group.

    Treatment: Sham intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness and Safety of Transcutaneous Electrical Stimulation With 40 kHz Alternating Currents in People With Spinal Cord Injury and Neuropathic Pain. A Randomised, Double-blind, Parallel Pilot Study With Placebo Control
Record updated
13 April 2026